Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment

Clinical trial NCT00425204 · COMPLETED

Trial details

NCT number: NCT00425204
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer Non-Small Cell Lung Cancer Prostate Cancer Solid Tumors Advanced Renal Cell Carcinoma

Start date: 2004-03-01
Primary completion: 2007-09-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.